H.C. Wainwright Downgrades Ocera Therapeutics (OCRX) to Neutral Following Acquisition
Tweet Send to a Friend
H.C. Wainwright downgraded Ocera Therapeutics (NASDAQ: OCRX) from Buy to Neutral with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
